Floatz logo

FILGRASTIM

AIDS-Related Plasmablastic Lymphoma

City of Hope Medical Centerprotein_peptidePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

23 Active assets in the AIDS-Related Plasmablastic Lymphoma cohort.

Asset / SponsorPhaseRating
Inno-206
National Cancer Institute (NCI)
Phase 2BB
PREDNISONE TABLETS
National Cancer Institute (NCI)
Phase 2BB
ETOPOSIDE
National Cancer Institute (NCI)
Phase 2BB
(+)-VINCRISTINE
National Cancer Institute (NCI)
Phase 2BB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 2BB

View all 27 →

Same molecule, other indications

FILGRASTIM is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
79 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →